Birdwatch Note
2024-11-17 02:56:53 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
「鉄タンパク質不足」によって片付けができなくなるという医学的根拠はありません。 プロフィールにある「分子栄養学」（Orthomolecular Therapy）は、科学的根拠が乏しいとされており、専門家や医療コミュニティの間でニセ科学（Quackery）とみなされています。 https://quackwatch.org/related/ortho/
Written by 5E4EEEAEFEC4653B759CA2693ACBC3AA1FFE1CD4BAE4AA88B66211844AF3FAD4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1857630963356045348
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1857981203623936140
- noteId - 1857981203623936140
- participantId -
- noteAuthorParticipantId - 5E4EEEAEFEC4653B759CA2693ACBC3AA1FFE1CD4BAE4AA88B66211844AF3FAD4 Participant Details
- createdAtMillis - 1731812213222
- tweetId - 1857630963356045348
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 「鉄タンパク質不足」によって片付けができなくなるという医学的根拠はありません。 プロフィールにある「分子栄養学」（Orthomolecular Therapy）は、科学的根拠が乏しいとされており、専門家や医療コミュニティの間でニセ科学（Quackery）とみなされています。 https://quackwatch.org/related/ortho/
Note Ratings
| rated at | rated by | |
| 2024-11-18 18:46:00 -0600 | Rating Details | |
| 2024-11-18 17:05:36 -0600 | Rating Details | |
| 2024-11-18 05:24:02 -0600 | Rating Details | |
| 2024-11-18 03:05:03 -0600 | Rating Details | |
| 2024-11-17 23:33:53 -0600 | Rating Details | |
| 2024-11-17 18:33:15 -0600 | Rating Details | |
| 2024-11-17 16:06:59 -0600 | Rating Details | |
| 2024-11-17 12:57:38 -0600 | Rating Details | |
| 2024-11-17 06:52:40 -0600 | Rating Details | |
| 2024-11-17 06:34:06 -0600 | Rating Details | |
| 2024-11-17 05:38:56 -0600 | Rating Details | |
| 2024-11-17 05:07:26 -0600 | Rating Details | |
| 2024-11-17 04:24:54 -0600 | Rating Details | |
| 2024-11-17 04:21:19 -0600 | Rating Details | |
| 2024-11-17 04:16:52 -0600 | Rating Details | |
| 2024-11-17 03:47:31 -0600 | Rating Details | |
| 2024-11-17 03:37:22 -0600 | Rating Details | |
| 2024-11-17 03:21:59 -0600 | Rating Details | |
| 2024-11-17 03:01:06 -0600 | Rating Details | |
| 2024-11-17 03:00:04 -0600 | Rating Details | |
| 2024-11-17 02:21:26 -0600 | Rating Details | |
| 2024-11-17 02:21:23 -0600 | Rating Details | |
| 2024-11-17 02:12:12 -0600 | Rating Details | |
| 2024-11-17 02:04:36 -0600 | Rating Details | |
| 2024-11-17 01:29:50 -0600 | Rating Details | |
| 2024-11-17 01:18:10 -0600 | Rating Details | |
| 2024-11-17 01:14:01 -0600 | Rating Details | |
| 2024-11-17 01:07:02 -0600 | Rating Details | |
| 2024-11-17 01:01:39 -0600 | Rating Details | |
| 2024-11-17 00:55:58 -0600 | Rating Details | |
| 2024-11-17 00:27:08 -0600 | Rating Details | |
| 2024-11-17 00:25:13 -0600 | Rating Details | |
| 2024-11-17 00:03:51 -0600 | Rating Details | |
| 2024-11-16 23:53:48 -0600 | Rating Details | |
| 2024-11-16 23:45:15 -0600 | Rating Details | |
| 2024-11-16 23:39:44 -0600 | Rating Details | |
| 2024-11-16 23:38:55 -0600 | Rating Details | |
| 2024-11-16 23:10:02 -0600 | Rating Details | |
| 2024-11-16 23:07:59 -0600 | Rating Details | |
| 2024-11-16 22:26:34 -0600 | Rating Details | |
| 2024-11-16 22:00:46 -0600 | Rating Details | |
| 2024-11-16 22:00:28 -0600 | Rating Details | |
| 2024-11-16 21:58:42 -0600 | Rating Details | |
| 2024-11-16 21:52:33 -0600 | Rating Details | |
| 2024-11-16 21:31:25 -0600 | Rating Details | |
| 2024-11-17 00:18:08 -0600 | Rating Details | |
| 2024-12-05 09:51:04 -0600 | Rating Details | |
| 2024-11-18 17:38:56 -0600 | Rating Details | |
| 2024-11-18 02:44:21 -0600 | Rating Details | |
| 2024-11-17 23:47:48 -0600 | Rating Details | |
| 2024-11-17 20:55:32 -0600 | Rating Details | |
| 2024-11-17 16:40:18 -0600 | Rating Details | |
| 2024-11-17 15:46:28 -0600 | Rating Details | |
| 2024-11-17 15:30:09 -0600 | Rating Details | |
| 2024-11-17 04:50:21 -0600 | Rating Details | |
| 2024-11-17 03:18:59 -0600 | Rating Details | |
| 2024-11-17 02:38:57 -0600 | Rating Details | |
| 2024-11-17 00:48:38 -0600 | Rating Details | |
| 2024-11-17 00:33:30 -0600 | Rating Details | |
| 2024-11-17 00:33:19 -0600 | Rating Details | |
| 2024-11-17 00:18:28 -0600 | Rating Details | |
| 2024-11-17 00:14:37 -0600 | Rating Details | |
| 2024-11-17 00:05:33 -0600 | Rating Details | |
| 2024-11-16 23:58:40 -0600 | Rating Details | |
| 2024-11-16 23:55:56 -0600 | Rating Details | |
| 2024-11-16 22:16:55 -0600 | Rating Details | |
| 2024-11-16 22:09:38 -0600 | Rating Details | |
| 2024-11-16 22:06:55 -0600 | Rating Details |